Life Science Products Market, By Product (Recombinant Proteins (Immune Checkpoint Regulators, Chemokines, Growth Factors, Cytokines, Colony Stimulating Factors, Hormones, Enzymes & Inhibitors, Others), Cell Lines (Immunotherapy Cell Lines, Ion Channel Cel

Life Science Products Market, By Product (Recombinant Proteins (Immune Checkpoint Regulators, Chemokines, Growth Factors, Cytokines, Colony Stimulating Factors, Hormones, Enzymes & Inhibitors, Others), Cell Lines (Immunotherapy Cell Lines, Ion Channel Cell Lines, GPCR Cell Lines, Cell Signaling Pathway Cell Lines, Gene Knockout Cell Lines, Cancer Cell Lines, Others), Antibodies (Immune Checkpoint Antibodies, Epitope Tag Antibodies, Isotype Control Antibodies (Research Use, In-vivo Grade), Primary Antibodies (Research Use, In-vivo Grade), Assay Antibodies (includes secondary antibodies), Others(Viable Tumor Samples, Tumor Tissue Microarrays)), By Application (Drug Discovery & Development, Basic Research, Toxicity Screening, Biopharmaceutical Production, Drug Screening, Tissue Engineering, Forensic Testing), By End User (Biopharmaceutical Companies, Contract Research Organizations (CROs), Academic & Research Institutes, Forensic Science Laboratories, Food & Beverage Companies, Diagnostic Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Life science products include laboratory supplies & accessories, cell culture & fermentation processes, cell therapy technologies, chromatography products, bioprocess filtration, fixed and live cell research through imaging and analysis, sample collection products, recombinant proteins, cell lines, and antibodies. These products are used for drug discovery, tissue engineering, drug screening, forensic testing, and genetic analysis. Increasing funding in the life science sector is expected to boost growth of the global life science products market over the forecast period. Moreover, R&D in rare diseases is also expected to aid in growth of the market.

Key features of the study:

This report provides in-depth analysis of the Life Science Products market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global Life Science Products market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abcam Plc., A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories Inc., BPS Bioscience Inc., Crown Bioscience Inc., Genscript Biotech Corporation, Merck Millipore Limited, PerkinElmer Inc., Sigma Aldrich Corp., and Thermo Fisher Scientific Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global Life Science Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Life Science Products market

Detailed Segmentation:

Life Science Products Market, By Product:
Recombinant Proteins
Immune Checkpoint Regulators
Chemokines
Growth Factors
Cytokines
Colony Stimulating Factors
Hormones
Enzymes & Inhibitors
Others
Cell Lines
Immunotherapy Cell Lines
Ion Channel Cell Lines
GPCR Cell Lines
Cell Signaling Pathway Cell Lines
Gene Knockout Cell Lines
Cancer Cell Lines
Others
Antibodies
Immune Checkpoint Antibodies
Epitope Tag Antibodies
Isotype Control Antibodies
Research Use
In-vivo Grade
Primary Antibodies
Research Use
In-vivo Grade
Assay Antibodies (includes secondary antibodies)
Others
Viable Tumor Samples
Tumor Tissue Microarrays
Life Science Products Market, By Application:
Drug Discovery & Development
Basic Research
Toxicity Screening
Biopharmaceutical Production
Drug Screening
Tissue Engineering
Forensic Testing
Life Science Products Market, By End User:
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Forensic Science Laboratories
Food & Beverage Companies
Diagnostic Centers
Others
Life Science Products Market, By Region:
North America
By Product:
Recombinant Proteins
Immune Checkpoint Regulators
Chemokines
Growth Factors
Cytokines
Colony Stimulating Factors
Hormones
Enzymes & Inhibitors
Others
Cell Lines
Immunotherapy Cell Lines
Ion Channel Cell Lines
GPCR Cell Lines
Cell Signaling Pathway Cell Lines
Gene Knockout Cell Lines
Cancer Cell Lines
Others
Antibodies
Immune Checkpoint Antibodies
Epitope Tag Antibodies
Isotype Control Antibodies
Research Use
In-vivo Grade
Primary Antibodies
Research Use
In-vivo Grade
Assay Antibodies (includes secondary antibodies)
Others
Viable Tumor Samples
Tumor Tissue Microarrays
By Application
Drug Discovery & Development
Basic Research
Toxicity Screening
Biopharmaceutical Production
Drug Screening
Tissue Engineering
Forensic Testing
By End User
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Forensic Science Laboratories
Food & Beverage Companies
Diagnostic Centers
Others
By Country:
U.S.
Canada
Latin America
By Product:
Recombinant Proteins
Immune Checkpoint Regulators
Chemokines
Growth Factors
Cytokines
Colony Stimulating Factors
Hormones
Enzymes & Inhibitors
Others
Cell Lines
Immunotherapy Cell Lines
Ion Channel Cell Lines
GPCR Cell Lines
Cell Signaling Pathway Cell Lines
Gene Knockout Cell Lines
Cancer Cell Lines
Others
Antibodies
Immune Checkpoint Antibodies
Epitope Tag Antibodies
Isotype Control Antibodies
Research Use
In-vivo Grade
Primary Antibodies
Research Use
In-vivo Grade
Assay Antibodies (includes secondary antibodies)
Others
Viable Tumor Samples
Tumor Tissue Microarrays
By Application
Drug Discovery & Development
Basic Research
Toxicity Screening
Biopharmaceutical Production
Drug Screening
Tissue Engineering
Forensic Testing
By End User
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Forensic Science Laboratories
Food & Beverage Companies
Diagnostic Centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product:
Recombinant Proteins
Immune Checkpoint Regulators
Chemokines
Growth Factors
Cytokines
Colony Stimulating Factors
Hormones
Enzymes & Inhibitors
Others
Cell Lines
Immunotherapy Cell Lines
Ion Channel Cell Lines
GPCR Cell Lines
Cell Signaling Pathway Cell Lines
Gene Knockout Cell Lines
Cancer Cell Lines
Others
Antibodies
Immune Checkpoint Antibodies
Epitope Tag Antibodies
Isotype Control Antibodies
Research Use
In-vivo Grade
Primary Antibodies
Research Use
In-vivo Grade
Assay Antibodies (includes secondary antibodies)
Others
Viable Tumor Samples
Tumor Tissue Microarrays
By Application
Drug Discovery & Development
Basic Research
Toxicity Screening
Biopharmaceutical Production
Drug Screening
Tissue Engineering
Forensic Testing
By End User
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Forensic Science Laboratories
Food & Beverage Companies
Diagnostic Centers
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product:
Recombinant Proteins
Immune Checkpoint Regulators
Chemokines
Growth Factors
Cytokines
Colony Stimulating Factors
Hormones
Enzymes & Inhibitors
Others
Cell Lines
Immunotherapy Cell Lines
Ion Channel Cell Lines
GPCR Cell Lines
Cell Signaling Pathway Cell Lines
Gene Knockout Cell Lines
Cancer Cell Lines
Others
Antibodies
Immune Checkpoint Antibodies
Epitope Tag Antibodies
Isotype Control Antibodies
Research Use
In-vivo Grade
Primary Antibodies
Research Use
In-vivo Grade
Assay Antibodies (includes secondary antibodies)
Others
Viable Tumor Samples
Tumor Tissue Microarrays
By Application
Drug Discovery & Development
Basic Research
Toxicity Screening
Biopharmaceutical Production
Drug Screening
Tissue Engineering
Forensic Testing
By End User
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Forensic Science Laboratories
Food & Beverage Companies
Diagnostic Centers
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product:
Recombinant Proteins
Immune Checkpoint Regulators
Chemokines
Growth Factors
Cytokines
Colony Stimulating Factors
Hormones
Enzymes & Inhibitors
Others
Cell Lines
Immunotherapy Cell Lines
Ion Channel Cell Lines
GPCR Cell Lines
Cell Signaling Pathway Cell Lines
Gene Knockout Cell Lines
Cancer Cell Lines
Others
Antibodies
Immune Checkpoint Antibodies
Epitope Tag Antibodies
Isotype Control Antibodies
Research Use
In-vivo Grade
Primary Antibodies
Research Use
In-vivo Grade
Assay Antibodies (includes secondary antibodies)
Others
Viable Tumor Samples
Tumor Tissue Microarrays
By Application
Drug Discovery & Development
Basic Research
Toxicity Screening
Biopharmaceutical Production
Drug Screening
Tissue Engineering
Forensic Testing
By End User
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Forensic Science Laboratories
Food & Beverage Companies
Diagnostic Centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product:
Recombinant Proteins
Immune Checkpoint Regulators
Chemokines
Growth Factors
Cytokines
Colony Stimulating Factors
Hormones
Enzymes & Inhibitors
Others
Cell Lines
Immunotherapy Cell Lines
Ion Channel Cell Lines
GPCR Cell Lines
Cell Signaling Pathway Cell Lines
Gene Knockout Cell Lines
Cancer Cell Lines
Others
Antibodies
Immune Checkpoint Antibodies
Epitope Tag Antibodies
Isotype Control Antibodies
Research Use
In-vivo Grade
Primary Antibodies
Research Use
In-vivo Grade
Assay Antibodies (includes secondary antibodies)
Others
Viable Tumor Samples
Tumor Tissue Microarrays
By Application
Drug Discovery & Development
Basic Research
Toxicity Screening
Biopharmaceutical Production
Drug Screening
Tissue Engineering
Forensic Testing
By End User
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Forensic Science Laboratories
Food & Beverage Companies
Diagnostic Centers
Others
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Abcam Plc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
A.M.S. Biotechnology (Europe) Limited
Bio-Rad Laboratories Inc.
BPS Bioscience Inc.
Crown Bioscience Inc.
Genscript Biotech Corporation
Merck Millipore Limited
PerkinElmer Inc.
Sigma Aldrich Corp.
Thermo Fisher Scientific Inc.
“*” marked represents similar segmentation in other categories in the respective section.